바이오인

   BUILDING THE BIOECONOMY 6TH EDITION

National Biotechnology Industry Development Strategies Globally

 

 

 

 

 

[내용]

LIST OF ABBREVIATIONS

---

EXECUTIVE SUMMARY

---

1 INTRODUCTION

1.1 Rising to the challenge ? biotechnologies for sustainability

1.2 Objectives of the 2019 edition of Building the Bioeconomy

1.3 Enabling factors for biotech success

1.4 A wider sample of national biotech policies

1.5 Report overview

---

2 THE STATE OF GLOBAL BIOTECHNOLOGY IN 2019

2.1 The story of the early 21st century: The rise of China

2.2 The future of global trading relations: Effective market access and 18 the protection of IP

2.3 One step forward, two steps back…

2.4 Cost control at all costs? Developments in biopharmaceutical pricing policies

2.5 Growing headwinds for IP protection

2.6 A ray of light? NAFTA 2.0

---

3 ZOOMING IN ON THE NEW COUNTRIES SAMPLED IN THE BUILDING HE BIOECONOMY

3.1 Laying the foundation: Algeria, Ecuador, Kenya, Nigeria and the Philippines

3.2 Reaching for biotech excellence: Canada, Lithuania, France, Germany, Netherlands and Norway

---

4 MEASURING POLICY IMPACT AND REAL-WORLD BIOTECHNOLOGY RESULTS ? THE BIOTECH POLICY PERFORMANCE MEASURE

4.1 Policy inputs

4.2 Biotech outputs

4.3 Green, yellow and red ? Traffic light classification system

4.4 The Biotech Policy Performance Measure ? Overall results

4.5 The Biotech Policy Performance Measure ? Discussion

---

5 FINAL THOUGHTS AND RECOMMENDATIONS

 

[요약]

EXECUTIVE SUMMARY

2019 marks the sixth edition of the Building the Bioeconomy series. Since 2013 it has taken the pulse of biotechnology policy frameworks by looking at their developments and overall performance in some of the major economies around the world. The overriding goal of this exercise has been to identify how successful biotechnology sectors can be built and sustained

 

Seven enabling factors for biotech success

The analysis and policy mapping of Building the Bioeconomy is built around seven enabling factors for biotechnology development. The factors range from the institutional and eco-system level (such as levels of tertiary education, technical skill and IP environment) to the more biotech specific (such as what type of biomedical and biotech R&D infrastructure does a country have in place and availability of technology transfer laws and mechanisms). Together these factors create the conditions that give countries and policymakers the best chance of having success in developing their biotech capacity and promoting biotech innovation.

 

...................(계속)

 

☞ 자세한 내용은 내용바로가기 또는 첨부파일을 이용하시기 바랍니다.